Projects are reviewed and selected for funding by a panel of experts. The 2025 (Round 16) panel:
- Prof John Skidmore (Chair), Chief Scientific Officer, ALBORADA Drug Discovery Institute
- Dr Rachel Atfield, Associate Director (Life Sciences), Cambridge Enterprise
- Dr Sarah Bolton, Business Manager, Centre for Healthcare Equipment and Technology Adoption (CHEATA), Nottingham University Hospitals NHS Trust
- Prof Steve Charnock-Jones, Department of Obstetrics and Gynaecology, University of Cambridge
- Dr Nadine Clemo, Global Program Leader, Apollo Therapeutics
- Dr Dominique-Laurent Couturier, MRC Biostatistics Unit, University of Cambridge
- Dr Erwin De Genst, Associate Principal Scientist in Biologics Engineering, AstraZeneca
- Dr Rajesh Jena, Department of Oncology, University of Cambridge and Cambridge University Hospitals NHS Foundation Trust
- Dr Andy Merritt, Head of Academic Engagement, LifeArc
- Prof Miles Parkes, Director, Cambridge Biomedical Research Centre
- Dr John Pritchard, Industry Expert in Residence at the University of Cambridge
- Prof Duncan Richards, Head of Department of Medicine, University of Cambridge
- Dr Iain Simpson, Director, Phillips-Medisize
- Mr Jacob Skinner, Regulatory Operations Manager, Global Regulatory Services
- Dr Ben Uttenthal, Department of Haematology, University of Cambridge and Cambridge University Hospitals NHS Foundation Trust
- Mr David Warwick, Director, EG Technology
- Prof Anne Willis OBE, MRC Toxicology Unit, University of Cambridge